- Home
- CDNA vs WOOF Comparison
CDNA vs WOOF Comparison
Compare CDNA & WOOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- WOOF
- Stock Information
- Founded
- CDNA 1998
- WOOF 1965
- Country
- CDNA United States
- WOOF United States
- Employees
- CDNA N/A
- WOOF N/A
- Industry
- CDNA Medical Specialities
- WOOF Other Specialty Stores
- Sector
- CDNA Health Care
- WOOF Consumer Discretionary
- Exchange
- CDNA Nasdaq
- WOOF Nasdaq
- Market Cap
- CDNA 1.0B
- WOOF N/A
- IPO Year
- CDNA 2014
- WOOF 2021
- Fundamental
- Price
- CDNA $20.13
- WOOF $2.97
- Analyst Decision
- CDNA Buy
- WOOF Buy
- Analyst Count
- CDNA 6
- WOOF 8
- Target Price
- CDNA $30.33
- WOOF $3.75
- AVG Volume (30 Days)
- CDNA 866.7K
- WOOF 3.9M
- Earning Date
- CDNA 07-30-2025
- WOOF 06-05-2025
- Dividend Yield
- CDNA N/A
- WOOF N/A
- EPS Growth
- CDNA N/A
- WOOF N/A
- EPS
- CDNA 1.07
- WOOF N/A
- Revenue
- CDNA $346,421,000.00
- WOOF $6,080,721,000.00
- Revenue This Year
- CDNA $13.31
- WOOF $0.04
- Revenue Next Year
- CDNA $15.46
- WOOF $1.41
- P/E Ratio
- CDNA $18.99
- WOOF N/A
- Revenue Growth
- CDNA 25.92
- WOOF N/A
- 52 Week Low
- CDNA $14.09
- WOOF $2.23
- 52 Week High
- CDNA $34.84
- WOOF $6.29
- Technical
- Relative Strength Index (RSI)
- CDNA 58.32
- WOOF 50.41
- Support Level
- CDNA $18.37
- WOOF $2.97
- Resistance Level
- CDNA $20.91
- WOOF $3.16
- Average True Range (ATR)
- CDNA 0.80
- WOOF 0.12
- MACD
- CDNA 0.06
- WOOF 0.05
- Stochastic Oscillator
- CDNA 69.88
- WOOF 68.85
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.